Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
about
Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter studyPrognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area.IMRT combined with concurrent chemotherapy plus adjuvant chemotherapy versus IMRT combined with concurrent chemotherapy alone in patients with nasopharyngeal carcinomaA risk score model for the metastasis of level Ib lymph node based on the clinicopathological features of nasopharyngeal carcinoma in a large sample.Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of ChinaThe role of microRNAs in nasopharyngeal carcinoma.Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma.Clinical Outcome among Nasopharyngeal Cancer Patients in a Multi-Ethnic Society in SingaporeIs Gemcitabine and Cisplatin Induction Chemotherapy Superior in Locoregionally Advanced Nasopharyngeal Carcinoma?Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled studyConcurrent chemoradiotherapy for T3-4 and N0-1 nasopharyngeal cancer: Asian multicenter trial of the Forum for Nuclear Cooperation in Asia.Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma.Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.EBV reactivation as a target of luteolin to repress NPC tumorigenesis.Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge.The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients.Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma.Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: a meta-analysis.Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway.Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.CT-diagnosed severe skull base bone destruction predicts distant bone metastasis in early N-stage nasopharyngeal carcinoma.Higher N stage and serum ferritin, but lower serum albumin levels are associated with distant metastasis and poor survival in patients with nasopharyngeal carcinoma following intensity-modulated radiotherapy.Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis.Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway.18 F-Fluoromisonidazole positron emission tomography/CT-guided volumetric-modulated arc therapy-based dose escalation for hypoxic subvolume in nasopharyngeal carcinomas: A feasibility study.The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.Impact of minimum point dose on local control and toxicity in T3-4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy.Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignanciesInduction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study
P2860
Q33436774-3258AB87-D48D-423B-A9BB-58F678C29C32Q33650637-F4937F72-8B60-4D69-947B-29C1522ED9BFQ33889336-6E46917A-9418-483B-8FDF-FCC15C3B0CB4Q33933003-3C8E0179-13FA-4551-8702-1F085E6032F7Q34465715-D04FC3E5-D41D-4CFA-80EA-89DD205DA1A2Q35043716-F3E98600-14B0-49BB-96A9-E50C0799CB57Q35072994-DF98C026-5115-4D7B-836B-F508BB15C4A4Q35117590-54AF4FFA-E12E-4067-B4D2-9EAD86908D5CQ35593518-5B097C43-0BEF-4561-8285-98BF56CBC7ECQ35597877-B52186EE-7A40-4758-8BD0-47F8A48689F9Q36111085-3D144514-5391-4A97-8621-63C5E55A549FQ36439727-084C87CE-22E0-400D-8EA7-16B4CA6C1353Q36451599-93A10022-6665-48BA-8490-B9E35D319891Q36618682-BBF7A715-B91C-4EEA-A1B5-A17323F82591Q36774647-7F35EB2E-415D-4BAB-9625-DAFB2EB1BB26Q37109915-D5074692-5EEB-4D83-B57F-852C58901C44Q37248002-EEA3E737-F3C3-450B-AEB9-61262D10EA25Q37370639-6481A7B9-3B72-4CAF-8F07-5ED03B7890D5Q37607361-CE6F2829-FA3C-47A8-A41C-6B87B592C228Q38133425-E7F0163A-A26D-4BAF-A5A0-B0871B6F5726Q38781428-92EC3319-6D8D-490A-9D8C-69923DB7D919Q41187529-EE918900-EB9F-45F6-A3E5-62416FD365EDQ42365111-D130E573-539B-4A88-846C-0B659648D257Q42700682-C72621EE-6406-4196-9586-290EC7588811Q47609586-5D429094-4EC3-49D7-BC07-0E9A04F03FDFQ47745693-79384627-7922-4CBA-A7AE-FFDDA0427B7BQ48265312-99C28352-D48A-4B98-9804-B2CA3BC0FF1BQ48819215-583DB34F-F937-45A5-95BD-50B365CDC4F9Q52732435-67F25BD8-B36B-4E28-ADE4-9485821F4FEDQ58698304-F22695FB-E1D5-49F8-9577-9B89C6371A48Q58786191-A0D14E5B-6A4E-497A-BD52-ADA13685704F
P2860
Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment outcomes for differe ...... ty-modulated radiation therapy
@ast
Treatment outcomes for differe ...... ty-modulated radiation therapy
@en
Treatment outcomes for differe ...... y-modulated radiation therapy.
@nl
type
label
Treatment outcomes for differe ...... ty-modulated radiation therapy
@ast
Treatment outcomes for differe ...... ty-modulated radiation therapy
@en
Treatment outcomes for differe ...... y-modulated radiation therapy.
@nl
prefLabel
Treatment outcomes for differe ...... ty-modulated radiation therapy
@ast
Treatment outcomes for differe ...... ty-modulated radiation therapy
@en
Treatment outcomes for differe ...... y-modulated radiation therapy.
@nl
P2093
P2860
P356
P1476
Treatment outcomes for differe ...... ty-modulated radiation therapy
@en
P2093
Chong Zhao
Chun-Yan Chen
Jia-Xin Li
Sheng-Fa Su
Tai-Xiang Lu
Wei-Wei Xiao
Ying Huang
P2860
P304
P356
10.5732/CJC.010.10547
P50
P577
2011-08-01T00:00:00Z